Zimmer Biomet
870 hedge funds and large institutions have $20B invested in Zimmer Biomet in 2018 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 287 increasing their positions, 324 reducing their positions, and 64 closing their positions.
55% more call options, than puts
Call options by funds: $87M | Put options by funds: $56.3M
33% more funds holding in top 10
Funds holding in top 10: 9 → 12 (+3)
2% more capital invested
Capital invested by funds: $19.6B → $20B (+$360M)
0% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 64
0.36% less ownership
Funds ownership: 91.1% → 90.74% (-0.36%)
1% less funds holding
Funds holding: 876 → 870 (-6)
11% less repeat investments, than reductions
Existing positions increased: 287 | Existing positions reduced: 324
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$320M |
| 2 |
CCM
Causeway Capital Management
Los Angeles,
California
|
+$133M |
| 3 |
JP Morgan Chase
New York
|
+$82.4M |
| 4 |
KP
Kiltearn Partners
Edinburgh,
United Kingdom
|
+$70.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$69.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$230M |
| 2 |
Goldman Sachs
New York
|
-$88.1M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
-$61.9M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$59.1M |
| 5 |
Two Sigma Advisers
New York
|
-$54.9M |
ZBH Hedge Fund Activity: Q2 2018 in Review
870 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2018, worth a combined $20B — up 1.8% from $19.6B a quarter earlier.
Fund positioning in ZBH was balanced in Q2 2018: 64 funds opened new positions, 64 closed out, 287 added to existing stakes and 324 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $320M. The largest seller was BlackRock, cutting an estimated $230M.
- 870 institutional investors held Zimmer Biomet (ZBH) as of Q2 2018, down from 876 in Q1 2018.
- Funds reported $20B of Zimmer Biomet stock for Q2 2018, up 1.8% quarter-over-quarter.
- 64 funds opened new Zimmer Biomet positions in Q2 2018 and 64 closed out, a net change of 0 holders.
- The largest Zimmer Biomet buyer in Q2 2018 was Wellington Management Group, an estimated $320M added.
- The largest Zimmer Biomet seller in Q2 2018 was BlackRock, an estimated $230M sold.
Based on aggregated 13F filings for Q2 2018.